Hypig 15 (Skin) (20 gm) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Dermocare Laboratories (Guj) Pvt Ltd. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Oxybenzone, Hydroquinone,Octyl Methoxycinnamate. This drug comes in the form of Cream. The general packing available for this medicine consists of 20 gm and is priced at Rs 34 (arround $0.476 US Dollar)
Oxybenzone Indication (Prescribed for or used as):
For more details on Oxybenzone, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Oxybenzone..
Hydroquinone Indication (Prescribed for or used as):
For more details on Hydroquinone, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Hydroquinone..
Octyl Methoxycinnamate Indication (Prescribed for or used as):
For more details on Octyl Methoxycinnamate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Octyl Methoxycinnamate..
Hypig 15 (Skin) (20 gm) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Hypig 15 (Skin) (20 gm), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Oxybenzone-3.0% w/w Hydroquinone-2% w/w Octyl Methoxycinnamate-5% w/w). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.